A5074307674- Transplantation: Methods and Outcomes
- Cystic Fibrosis Research Advances
- Antifungal resistance and susceptibility
- Tracheal and airway disorders
- Renal Transplantation Outcomes and Treatments
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Pneumocystis jirovecii pneumonia detection and treatment
- Fungal Infections and Studies
- Inhalation and Respiratory Drug Delivery
- Organ Transplantation Techniques and Outcomes
- Respiratory viral infections research
- Polyomavirus and related diseases
- Animal Disease Management and Epidemiology
- Mechanical Circulatory Support Devices
- Cytomegalovirus and herpesvirus research
- Pneumonia and Respiratory Infections
- Neonatal Respiratory Health Research
- Viral gastroenteritis research and epidemiology
- Mycobacterium research and diagnosis
- Animal Virus Infections Studies
- Vector-Borne Animal Diseases
- Pleural and Pulmonary Diseases
- Hematological disorders and diagnostics
- Nematode management and characterization studies
- Respiratory and Cough-Related Research
Hospital Universitari i Politècnic La Fe
2016-2025
Universitat de València
2015-2024
Universitat Politècnica de Catalunya
2024
Instituto de Investigación Sanitaria La Fe
2014-2021
University of Alicante
2018
Leitat Technological Center
2007-2017
Red Espanola de Investigacion en Patologia Infecciosa
2016
Central University Hospital of Asturias
2016
Universidad de Oviedo
2016
Imation (United States)
2016
Tens of thousands patients with advanced lung diseases may be eligible to considered as potential candidates for transplant around the world each year. The timing referral, evaluation, determination candidacy, and listing continues pose challenges even ethical dilemmas. To address these challenges, International Society Heart Lung Transplantation appointed an international group members review literature, consider recent advances in management diseases, update prior consensus documents on...
<h3>Background</h3> Individuals with chronic diseases and parent caregivers are at increased risk for symptoms of depression anxiety. Prevalence psychological was evaluated in adolescents adults cystic fibrosis (CF) across nine countries. <h3>Methods</h3> Patients CF, ages 12 years older, children birth to18 age, completed measures anxiety 154 CF centres Europe the USA. Psychological were compared countries using χ<sup>2</sup>. Logistic regression examined extent comorbid symptoms,...
In the absence of standardized diagnosis and presence unique clinical syndromes, it is not surprising that considerable differences exist in number reported incidences disease outcomes various infections cardiothoracic transplant (CTTX) recipients. Publications to date have employed variable heterogeneous definitions CTTX-related infections, thereby limiting comparison between types incidence generalizability these data across centers. Currently, there are no standard international for...
The improved survival in people with cystic fibrosis has led to an increasing number of patients reaching adulthood. This trend is likely be maintained over the next decades, suggesting a need increase centres expertise management adult fibrosis. These should capable delivering multidisciplinary care addressing complexity disease, addition psychological burden on and their families. Further issues that require attention are organ transplantation end life management. Lung disease adults...
Everolimus is a proliferation signal inhibitor with immunosuppressive activity that may reduce the rate of progression chronic rejection, bronchiolitis obliterans syndrome (BOS), after lung transplantation. In randomized, double-blind clinical trial, 213 BOS-free maintenance patients received everolimus (3 mg/day) or azathioprine (AZA, 1-3 mg/kg/day) in combination cyclosporine and corticosteroids. The prospectively defined primary endpoint was incidence efficacy failure (decline FEV1...
There are no European recommendations on issues specifically related to lung transplantation (LTX) in cystic fibrosis (CF). The main goal of this paper is provide CF care team members with clinically relevant CF-specific information all aspects LTX, highlighting areas consensus and controversy throughout Europe. Bilateral has been shown be an important therapeutic option for end-stage pulmonary disease. Transplant function patient survival after better than most other indications procedure....
The epidemiology of respiratory viruses (RVs) in lung transplant recipients (LTRs) and the relationship RVs to function, acute rejection (AR) opportunistic infections these patients are not well known. We performed a prospective cohort study (2009–2014) by collecting nasopharyngeal swabs (NPSs) from asymptomatic LTRs during seasonal changes with upper tract infectious disease (URTID), lower (LRTID) AR. NPSs were analyzed multiplex polymerase chain reaction. Overall, 1094 collected 98 23.6%...
Introduction Risk stratification for CMV infection in lung transplantation (LT) currently relies on determining donor and recipient IgG before transplantation. However, it has been observed that some patients who test positive CMV-specific humoral response kidney (KT) exhibit a weak or absent cellular response. The significance of this observation LT is still unknown. Methods This prospective, multicenter, observational study evaluated the agreement between serology specific cell-mediated...